Neuronal degeneration is a major histopathologic finding in Alzheimer's disease (AD). Selective vulnerability of subpopulations of subcortical neurons has previously been described. We recently described retinal ganglion cell loss and optic neuropathy, all in the absence of neuritic plaques, neurofibrillary tangles and amyloid angiopathy. Clinically, some AD patients show changes in visual evoked responses. Although the CNS contains heterogeneous cell populations, a monoclonal antibody marker (MAb 3F12) has identified some of the vulnerable neurons in the neocortex, hippocampus, and possibly the axons of retinal ganglion cells undergoing degeneration. Little is known of the molecular specificities of these cells in normal or AD brain or retina. IN this study we propose to analyze neuronal-specific function at three levels: clinical, histologic, and molecular. For the clinical studies we shall focus on the visual system, integrating the neurologic and psychometric database with specific visual function studies. Patients will be followed to autopsy and retinal ganglion cell loss assessed. A parallel histologic assessment of auditory system neuronal changes will be made. Temporal progression of neuronal loss in AD will be examined. With use of neuron-specific monoclonal probes, the architectonic differences in neuronal changes in AD will also be compared to other dementing diseases (Pick's, Parkinson's). The AD-vulnerable neurons will be further defined by: (1) immunocytochemical identification of their associated neurotransmitter and neuropeptides, (2) molecular characterization of Ag3F12, and (3) development of a neuron-enriched cDNA library. MAb 3F12 will be used to isolate clones from a human brain cDNA expression library, localization confirmed by combined in situ hybridization and immunoperoxidase staining. Isolated 3F12 cDNA clones will be useful as markers of pyramidal cell enrichment in preparation of a new neuron-enriched cDNA library. To enhance isolation of rare or low abundance mRNA species, we shall use subtraction hybridization methods. Transcripts will be screened by Northern and Southern blot analyses, and positives by in situ hybridization in normal and AD neocortex, hippocampus and retina. Proteins and/or transcripts of interest will be sequenced to determine if they are of known molecular specificity. Development of this neuronal subset-specific molecular panel may contribute to the understanding of regulatory mechanisms operative in these cells in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH039145-15
Application #
2674825
Study Section
Special Emphasis Panel (NSS)
Project Start
1984-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
2000-05-31
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Southern California
Department
Pathology
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Dong, Zhaohui; Zhou, Li; Del Villar, Keith et al. (2005) JIP1 regulates neuronal apoptosis in response to stress. Brain Res Mol Brain Res 134:282-93
Del Villar, Keith; Miller, Carol A (2004) Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci U S A 101:4210-5
Kumagae, Y; Zhang, Y; Kim, O J et al. (1999) Human c-Jun N-terminal kinase expression and activation in the nervous system. Brain Res Mol Brain Res 67:10-7
Zhang, Y; Zhou, L; Miller, C A (1998) A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system. Proc Natl Acad Sci U S A 95:2586-91
Williams, C; Villegas, M; Atkinson, R et al. (1998) Chondroitin sulfate proteoglycan specific to retinal horizontal neurons. J Comp Neurol 390:268-77
Zhou, L; Miller, B L; McDaniel, C H et al. (1998) Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration. Ann Neurol 44:99-109
Zhou, L; Chomyn, A; Attardi, G et al. (1997) Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates. J Neurosci 17:7746-53
Sinha, U K; Saadat, D; Linthicum Jr, F H et al. (1996) Temporal bone findings in Alzheimer's disease. Laryngoscope 106:1-5
Lim, G P; Backstrom, J R; Cullen, M J et al. (1996) Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67:251-9
Martin, J H; Mohit, A A; Miller, C A (1996) Developmental expression in the mouse nervous system of the p493F12 SAP kinase. Brain Res Mol Brain Res 35:47-57

Showing the most recent 10 out of 16 publications